Royal Bank of Canada’s GT Biopharma GTBP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5
| Closed | – | – | 6477 |
|
|
2024
Q3 | $0 | Sell |
5
-2
| -29% | – | ﹤0.01% | 6578 |
|
|
2024
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 6790 |
|
|
2024
Q1 | $0 | Sell |
7
-2,190
| -100% | – | ﹤0.01% | 6701 |
|
|
2023
Q4 | $0 | Sell |
2,197
-239
| -10% | – | ﹤0.01% | 6716 |
|
|
2023
Q3 | $0 | Sell |
2,436
-1,383
| -36% | – | ﹤0.01% | 6731 |
|
|
2023
Q2 | $2K | Buy |
3,819
+1,311
| +52% | +$687 | ﹤0.01% | 6413 |
|
|
2023
Q1 | $1K | Sell |
2,508
-279,450
| -99% | -$111K | ﹤0.01% | 6501 |
|
|
2022
Q4 | $250K | Buy |
281,958
+279,890
| +13,534% | +$248K | ﹤0.01% | 4227 |
|
|
2022
Q3 | $3K | Buy |
2,068
+110
| +6% | +$160 | ﹤0.01% | 6397 |
|
|
2022
Q2 | $6K | Sell |
1,958
-1,091
| -36% | -$3.34K | ﹤0.01% | 6111 |
|
|
2022
Q1 | $9K | Sell |
3,049
-3,328
| -52% | -$9.82K | ﹤0.01% | 6505 |
|
|
2021
Q4 | $20K | Buy |
6,377
+2,243
| +54% | +$7.04K | ﹤0.01% | 6269 |
|
|
2021
Q3 | $28K | Buy |
4,134
+544
| +15% | +$3.69K | ﹤0.01% | 5979 |
|
|
2021
Q2 | $55K | Sell |
3,590
-20,952
| -85% | -$321K | ﹤0.01% | 5482 |
|
|
2021
Q1 | $167K | Buy |
+24,542
| New | +$167K | ﹤0.01% | 4615 |
|